RT-3 is a research-grade synthetic peptide reagent functioning as a triple agonist at GIP, incretin, and glucagon receptor subtypes. This first-in-class multi-receptor agonist has emerged as one of the most significant tools in contemporary metabolic signaling research, owing to its ability to engage three distinct G protein-coupled receptors through a single molecular entity. In cellular assay systems, RT-3 has demonstrated balanced agonist activity across all three target receptors, enabling investigators to study the complex interplay between these complementary signaling pathways.

Published research has examined RT-3’s effects on pancreatic islet cell function, hepatic glucose output signaling, and lipid metabolism pathways in adipocyte models. The triple-agonist mechanism provides a unique experimental platform for investigating how multi-target receptor engagement produces metabolic outcomes distinct from dual or single receptor activation paradigms. Each vial is supplied as a lyophilized powder with documented purity exceeding 97% by HPLC, accompanied by complete analytical records including mass spectrometry data.

Ares Research supplies RT-3 exclusively for use by qualified researchers in established laboratory settings. This product is not intended for human or animal use.

FDA Disclaimer

The information presented on this website has not been evaluated by the U.S. Food and Drug Administration. No content on this site, nor any product listed, is intended to diagnose, treat, cure, or prevent any disease or medical condition.

All products are supplied solely as laboratory research reagents and are not for human consumption. Ares Research does not supply products to patients and makes no representations regarding therapeutic or medical use.

Ares Research operates as a chemical supplier only. It is not a compounding pharmacy and does not function as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.